Information for "PI3KAKTmTOR pathway adjustments to innovative NSCLC sufferers soon after progression on EGFRTKI and also scientific reply to EGFRTKI as well as everolimus combination treatments"
From EECH Central
Basic information
| Display title | PI3KAKTmTOR pathway adjustments to innovative NSCLC sufferers soon after progression on EGFRTKI and also scientific reply to EGFRTKI as well as everolimus combination treatments |
| Default sort key | PI3KAKTmTOR pathway adjustments to innovative NSCLC sufferers soon after progression on EGFRTKI and also scientific reply to EGFRTKI as well as everolimus combination treatments |
| Page length (in bytes) | 3,427 |
| Page ID | 1311296 |
| Page content language | English (en) |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
Page protection
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
Edit history
| Page creator | Skirtyear0 (Talk | contribs) |
| Date of page creation | 08:55, 28 March 2024 |
| Latest editor | Skirtyear0 (Talk | contribs) |
| Date of latest edit | 08:55, 28 March 2024 |
| Total number of edits | 1 |
| Total number of distinct authors | 1 |
| Recent number of edits (within past 90 days) | 1 |
| Recent number of distinct authors | 1 |
